运用归脾汤治疗维持性血液透析贫血患者的临床疗效分析  

Clinical Efficacy Analysis of Guipi Decoction in the Treatment of Anemia in Patients undergoing Hemodialysis

作　　者：程小明[1] 黄献华[1] 姚丽娟[1] 

机构地区：[1]广东省惠州市中医医院中药房,惠州516001

出　　处：《世界中医药》2014年第11期1482-1484,共3页World Chinese Medicine

摘　　要：目的:观察归脾汤治疗维持性血液透析贫血患者的临床疗效。方法:将74例维持性血液透析患者根据随机数字表法分为治疗组和对照组,每组37人,对照组进行常规治疗,治疗组在常规治疗的基础上加用归脾汤,每日1剂,煎服。2组患者分别于治疗前及治疗2个疗程后采集空腹外周静脉血标本,检测红细胞压积(Hct)、血红蛋白(Hb)、红细胞计数(RBC)、转铁蛋白饱和度(Ts)、血清铁蛋白(SF)并进行比较。结果:1)治疗组3例无效,总有效率为91.9%(34/37),明显高于对照组的73.0%,差异具有统计学意义(P<0.05)。2)2个疗程后,治疗组的Hct为(32.15±4.22)%,Hb水平为(97.36±13.16)g/L,Ts为(30.51±7.41)%,SF的含量为(155.21±132.56)μg/L,均优于对照组,差异均具有统计学意义(P<0.05)。结论:中药归脾汤治疗维持性血液透析贫血疗效显著,可以在临床上推广应用。Objective：To observe clinical efficacy of Guipi Decoction in the treatment of anemia in patients undergoing hemodialysis. Methods：74 hemodialysis patients were divided into treatment group and control group according to the random number table,the con-trol group used routine treatments,the treatment group used Guipi Decoction in addition to routine treatments.Hct、Hb、RBC、Ts and SF of two groups were compared.Results：1）the total effective rate of treatment group was 91.9% （34 /37）,significantly higher than 73. 0% of the control group,the difference was statistically significant （P 〈0.05）.2）After treatment,in the treatment group,the Hct was （32.15 ±4.22）%,Hb levels （97.36 ±13.16）g /L,Ts was （30.51 ±7.41）%,SF content was （155.21 ±132.56）ug /L,all were better than the control group,the differences were statistically significant （P 〈0.05）.Conclusion：Guipi Decoction was effective for treating anemia in hemodialysis patients,it can widely used in clinical medicine.

关 键 词：归脾汤 血液透析 贫血 血常规 血清铁蛋白 

分 类 号：R259[医药卫生—中西医结合]